Lisa D. MacDonald, Alecia MacKay, Valarmathy Kaliaperumal, Genevieve Weir, Andrea Penwell, Rajkannan Rajagopalan, . . . Marianne M. Stanford. (2018). Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform. Taylor & Francis Group.
Chicago Style (17th ed.) CitationLisa D. MacDonald, et al. Type III Hypersensitivity Reactions to a B Cell Epitope Antigen Are Abrogated Using a Depot Forming Vaccine Platform. Taylor & Francis Group, 2018.
MLA (9th ed.) CitationLisa D. MacDonald, et al. Type III Hypersensitivity Reactions to a B Cell Epitope Antigen Are Abrogated Using a Depot Forming Vaccine Platform. Taylor & Francis Group, 2018.
Warning: These citations may not always be 100% accurate.